一个由塞米普利马布 (cemiplimab) 管理引起的irAE胃炎病例
Kurumi Isomura1, Kyohei Takada1, Ryoko Ichikawa1
1Department of Obstetrics and Gynecology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Fujita medical journal
|February 5, 2026
概括
与免疫相关的胃炎是免疫检查点抑制剂 (ICI) 的罕见副作用. 本病例报告详细介绍了一名患者在接受了塞米普利马布治疗后出现胃炎,并用普雷迪尼索隆成功治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 免疫检查点抑制剂 (ICI) 可以引起与免疫相关的不良事件 (irAEs).
- 胃炎是一种与ICI治疗相关的罕见的IRAE.
- 塞米普利马布是一种用于治疗各种癌症的ICI.
研究的目的:
- 报告在西米普利马布 (cemiplimab) 后出现免疫相关胃炎的病例.
- 审查与ICI相关的免疫相关胃炎的文献.
- 为了突出CEMIPLIMAB诱导的胃炎的诊断和治疗方面的考虑.
主要方法:
- 介绍了一例75岁的女性,她因宫癌而接受了塞米普利马布治疗.
- 详细介绍了临床表现,上部内镜和组织病理学发现.
- 进行了与ICI相关的irAE胃炎的文献审查.
主要成果:
- 患者在接受塞米普利马布治疗后出现胃炎症状,包括厌食症,恶心和吐.
- 内镜检查结果显示粘膜红斑,,易碎性和白色排泄物.
- 组织病理学揭示了CD8阳性淋巴细胞的密集内皮层透,与irAE胃炎一致.
- 用普得尼索隆治疗导致症状改善和内镜检查结果的解决.
结论:
- 免疫相关的胃炎可能会在治疗赛米普利马布后发生.
- 诊断依赖于特征性的内镜和组织病理学特征.
- 普雷尼索隆是一种有效的治疗CEMIPLIMAB诱导的免疫相关胃炎.
相关概念视频
Gastritis-II: Pathophysiology
1.3K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.3K
Gastritis-I: Introduction and Types
2.4K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.4K
Gastritis III: Clinical Manifestations and Management
1.3K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.3K
Additional Routes of Drug Administration
4.9K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
4.9K
Routes of Drug Administration: Enteral
6.5K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
6.5K
Routes of Drug Administration: Parenteral
2.9K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.9K


